SFS
VXRT

Signator Financial Services’s Vaxart VXRT Stock Holding History

Signator Financial Services’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$0 Hold
3
– – ﹤0.01% 301
2013
Q2 		$0 Buy
+3
New +$125 ﹤0.01% 293

Other funds holding VXRT

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TL
TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Signator Financial Services's VXRT Position: Q3 2013 in Review

Signator Financial Services held its Vaxart (VXRT) position steady in Q3 2013 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Signator Financial Services first reported a position in VXRT in Q2 2013 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold VXRT as of Q3 2013.

  • Signator Financial Services held 3 shares of Vaxart worth $0 as of Q3 2013.
  • Signator Financial Services left its Vaxart share count unchanged in Q3 2013.
  • Vaxart made up ﹤0.01% of Signator Financial Services's portfolio in Q3 2013, its #301 holding.
  • Signator Financial Services first reported a position in Vaxart in Q2 2013 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Vaxart as of Q3 2013.

Based on Signator Financial Services's 13F filing for Q3 2013, filed 25 Aug 2014.